IP Library › Granted Patent US 11,291,642
Granted Patent B2
US 11,291,642 · App. 15/737,011 · Granted Apr 5, 2022

Dimethyl fumarate particles and pharmaceutical compositions thereof

Inventors: Pierre Boulas (Andover, MA); Erwin Irdam (Melrose, MA); Shyam B. Karki (Hillsborough, NJ); William F. Kiesman (Wayland, MA); Cheuk-Yui Leung (Acton, MA); Yiqing Lin (Lexington, MA); Andrea Trementozzi (Sherborn, MA); Peter Zawaneh (Brookline, MA)
Assignee: BIOGEN MA INC.
A61K31/225A61K9/0002A61K9/0065A61K9/14A61K9/1635A61K9/4808A61K9/5026A61K9/5084A61K47/10A61K47/14A61K47/42A61K9/1682A61P25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,291,642
App. No.
15/737,011
Granted
Apr 5, 2022
Kind
B2
Abstract

The present invention provides dimethyl fumarate (DMF) particles and methods of preparing the DMF particles. Also provided is DMF coated particles comprising DMF particles coated with an enteric coating. The invention also provides various dosage forms and methods of treating a disease or disorder (e.g., multiple sclerosis).

Claims (17)

1. A composition comprising dimethyl fumarate (DMF) particles having a volume median diameter (D 50 ) between 50 μm and 100 μm, wherein the span ((D 90 −D 10 )/D 50 ) of the DMF particles in the composition is in the range of 1.3 to 1.9; wherein the DMF particles are characterized by one or more of a)-c):

a) a circularity value in the range of 0.8 to 0.95;

b) an aspect ratio in the range of 0.55 to 1.0; and

c) a convexity value in the range of 0.95 to 1.0.

2. The composition of claim 1 , wherein the span ((D 90 −D 10 )/D 50 ) is in the range of 1.5 to 1.8.

3. The composition of claim 1 , wherein less than 10% of the particles have a particle size below 10 μm.

4. The composition of claim 1 , wherein the particles have a flow rate index in the range of 1.0 to 1.7.

5. The composition of claim 1 , wherein specific energy (SE) of the particles is in the range of 4.0 to 13.0.

6. The composition of claim 1 , wherein the particles have a flow function in the range of 2.0 to 20.0.

7. The composition of claim 1 , wherein when the particles undergo permeability test at 1 kPa, the pressure drop is less than 0.4 mBar.

8. The composition of claim 1 , wherein when the particles undergo permeability test at 15 kPa, the pressure drop is less than 0.5 mBar.

9. The composition of claim 1 , wherein greater than 30% of the particles have intensity less than 80 when measured with a Malvern Morphologi G3 instrument.

10. The composition of claim 1 , wherein 40% of the particles by accumulated volume have a circularity value in the range of 0.8 to 0.9.

11. A process for preparing the DMF particles of claim 1 , wherein the process comprises the step of reducing DMF particle size by wet-milling.

12. DMF particles prepared by the process according to claim 11 .

13. The composition of claim 1 , wherein the DMF particles are prepared by a process comprising the step of reducing DMF particle size by wet-milling.

14. The composition of claim 1 , wherein the DMF particles have a) a circularity value in the range of 0.8 to 0.95; b) an aspect ratio in the range of 0.55 to 1.0; and c) a convexity value in the range 0.95 to 1.0.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2018
From: BOULAS, PIERRE; IRDAM, ERWIN; KARKI, SHYAM B.; KIESMAN, WILLIAM F.; LEUNG, CHEUK-YUI; LIN, YIQING; TREMENTOZZI, ANDREA; ZAWANEH, PETER
To: BIOGEN MA INC.
Reel/Frame 045432/0535 →
Continuity (2)
Provisional Application 62181061 · Jun 17, 2015
Related Publication 20190070143A1 · Mar 7, 2019
Cited By (2)
US 12,303,604 US 12,599,563